| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing vericiguat (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vericiguat only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing vericiguat in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely vericiguat 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely vericiguat 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vericiguat only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vericiguat 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vericiguat 2.5 mg oral tablet |
Has precise active ingredient |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely vericiguat 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely vericiguat 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Vericiguat (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]